Co-Diagnostics (CODX) Competitors $0.92 -0.01 (-1.41%) (As of 11:51 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends CODX vs. FONR, EDAP, LNSR, VANI, NSPR, ECOR, HYPR, MLSS, MGRM, and APYXShould you be buying Co-Diagnostics stock or one of its competitors? The main competitors of Co-Diagnostics include FONAR (FONR), Edap Tms (EDAP), LENSAR (LNSR), Vivani Medical (VANI), InspireMD (NSPR), electroCore (ECOR), Hyperfine (HYPR), Milestone Scientific (MLSS), Monogram Orthopaedics (MGRM), and Apyx Medical (APYX). These companies are all part of the "medical equipment" industry. Co-Diagnostics vs. FONAR Edap Tms LENSAR Vivani Medical InspireMD electroCore Hyperfine Milestone Scientific Monogram Orthopaedics Apyx Medical FONAR (NASDAQ:FONR) and Co-Diagnostics (NASDAQ:CODX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, community ranking, risk, analyst recommendations, institutional ownership, valuation and earnings. Is FONR or CODX more profitable? FONAR has a net margin of 9.41% compared to Co-Diagnostics' net margin of -563.93%. FONAR's return on equity of 6.10% beat Co-Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets FONAR9.41% 6.10% 4.58% Co-Diagnostics -563.93%-54.94%-49.28% Does the MarketBeat Community favor FONR or CODX? Co-Diagnostics received 93 more outperform votes than FONAR when rated by MarketBeat users. However, 74.69% of users gave FONAR an outperform vote while only 62.90% of users gave Co-Diagnostics an outperform vote. CompanyUnderperformOutperformFONAROutperform Votes18074.69% Underperform Votes6125.31% Co-DiagnosticsOutperform Votes27362.90% Underperform Votes16137.10% Do institutionals and insiders believe in FONR or CODX? 50.6% of FONAR shares are held by institutional investors. Comparatively, 15.0% of Co-Diagnostics shares are held by institutional investors. 2.2% of FONAR shares are held by insiders. Comparatively, 6.1% of Co-Diagnostics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more risk & volatility, FONR or CODX? FONAR has a beta of 1.21, indicating that its share price is 21% more volatile than the S&P 500. Comparatively, Co-Diagnostics has a beta of -0.84, indicating that its share price is 184% less volatile than the S&P 500. Do analysts rate FONR or CODX? Co-Diagnostics has a consensus target price of $1.50, indicating a potential upside of 60.03%. Given Co-Diagnostics' stronger consensus rating and higher probable upside, analysts clearly believe Co-Diagnostics is more favorable than FONAR.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score FONAR 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Co-Diagnostics 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has preferable earnings & valuation, FONR or CODX? FONAR has higher revenue and earnings than Co-Diagnostics. Co-Diagnostics is trading at a lower price-to-earnings ratio than FONAR, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFONAR$102.88M0.99$10.57M$1.4011.48Co-Diagnostics$7.32M4.09-$35.33M-$1.38-0.68 Does the media refer more to FONR or CODX? In the previous week, FONAR and FONAR both had 2 articles in the media. FONAR's average media sentiment score of 1.43 beat Co-Diagnostics' score of 0.44 indicating that FONAR is being referred to more favorably in the media. Company Overall Sentiment FONAR Positive Co-Diagnostics Neutral SummaryFONAR beats Co-Diagnostics on 11 of the 16 factors compared between the two stocks. Ad Porter & CompanyThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry. Get Co-Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for CODX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CODX vs. The Competition Export to ExcelMetricCo-DiagnosticsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$29.93M$4.54B$5.23B$8.96BDividend YieldN/A43.03%5.24%4.05%P/E Ratio-0.6814.9598.6914.63Price / Sales4.0952.741,484.9296.07Price / CashN/A55.4241.8238.51Price / Book0.475.766.116.18Net Income-$35.33M$13.60M$117.65M$224.75M7 Day Performance0.78%2.64%2.86%1.98%1 Month Performance-22.54%7.38%1.79%9.78%1 Year Performance-27.34%46.32%35.89%29.97% Co-Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CODXCo-Diagnostics4.0354 of 5 stars$0.92-1.4%$1.50+62.3%-27.3%$29.51M$6.81M-0.67100Short Interest ↑FONRFONAR2.553 of 5 stars$16.08-2.4%N/A-16.2%$101.79M$102.88M11.76480Short Interest ↓Positive NewsEDAPEdap Tms3.6127 of 5 stars$2.38-2.5%$19.00+698.3%-51.6%$88.30M$65.42M-3.75307Positive NewsLNSRLENSAR2.2957 of 5 stars$7.48-0.7%$8.00+7.0%+194.9%$86.88M$48.87M-5.16110Positive NewsVANIVivani Medical3.6486 of 5 stars$1.45+0.3%$3.00+107.6%+51.6%$85.60MN/A-3.2020Positive NewsNSPRInspireMD2.3693 of 5 stars$2.95+0.3%$4.50+52.5%+26.6%$76.95M$6.82M-3.8750ECORelectroCore0.7266 of 5 stars$11.21-8.1%N/A+93.0%$73.43M$16.03M-6.3650High Trading VolumeHYPRHyperfine3.1736 of 5 stars$0.97-3.7%$1.60+64.4%-24.8%$70.99M$13.26M-1.77190Positive NewsMLSSMilestone Scientific2.2861 of 5 stars$0.90-9.2%$1.25+39.0%+13.9%$70.05M$9.83M-14.1430MGRMMonogram Orthopaedics1.606 of 5 stars$2.03+0.5%N/A-44.9%$69.65M$370,000.00-4.3028News CoveragePositive NewsAPYXApyx Medical2.7963 of 5 stars$1.82+13.0%N/A-18.5%$68.51M$48.54M-2.25270Positive News Related Companies and Tools Related Companies FONR Competitors EDAP Competitors LNSR Competitors VANI Competitors NSPR Competitors ECOR Competitors HYPR Competitors MLSS Competitors MGRM Competitors APYX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CODX) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Co-Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Co-Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
